S7499 | Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs | Smith & Moses
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
2021-2022 SessionJulia SalazarAffects: Insurance Law
Status
In Assembly Committee
Health
Impact Rating
Unable to calculate
Passage Likelihood
Unable to calculate
Bill Progress
✓
Introduced
✓
In Committee
✓
Committee Passed
✓
Floor Calendar
✓
Passed Chamber
🔄
Other Chamber
✓
Introduced
✓
In Committee
✓
Committee Passed
✓
Floor Calendar
✓
Passed Chamber
🔄
Other Chamber
What's Happening
Why It Matters
Waiting for summary...
Get alerts when S7499 moves
Create a free account to track this bill and get emailed when its status changes — committee votes, floor action, signing, or veto.